WallStSmart
MDLN

Medline Inc. Class A Common Stock

NASDAQ: MDLN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$39.25
-2.44% today

Updated 2026-06-05

Market cap
$30.23B
P/E ratio
31.36
P/S ratio
1.04x
EPS (TTM)
$1.14
Dividend yield
52W range
$33 – $51
Volume
9.2M

Medline Inc. Class A Common Stock (MDLN) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2022202320242025
Revenue$21.45B$23.23B$25.51B$28.43B
Revenue growth (YoY)+8.3%+9.8%+11.5%
Cost of revenue$16.89B$18.01B$19.22B$20.91B
Gross profit$4.56B$5.22B$6.29B$7.52B
Gross margin21.2%22.5%24.7%26.4%
R&D$58.00M$60.00M$67.00M
SG&A$4.52B
Operating income$870.00M$1.44B$2.23B$2.21B
Operating margin4.1%6.2%8.7%7.8%
EBITDA$1.85B$2.59B$3.53B$2.92B
EBITDA margin8.6%11.1%13.8%10.3%
EBIT$921.00M$1.64B$2.56B$2.21B
Interest expense$911.00M$1.38B$1.31B$812.00M
Income tax$35.00M$30.00M$46.00M
Effective tax rate350.0%11.4%3.7%0.0%
Net income$-25.00M$234.00M$1.20B$1.16B
Net income growth (YoY)+1036.0%+412.8%-3.4%
Profit margin-0.1%1.0%4.7%4.1%

Frequently asked questions

What is Medline Inc. Class A Common Stock's revenue?

Medline Inc. Class A Common Stock's trailing twelve-month revenue is $29.14B, and consensus projects about $41.91B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is MDLN?

In its most recent fiscal year, MDLN ran a gross margin of 26.44%, an operating margin of 7.78%, and a net margin of 4.08%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does MDLN generate?

MDLN produced $1.30B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is MDLN's balance sheet healthy?

MDLN holds $1.94B in cash and equivalents against $12.48B in long-term debt, on $10.74B of shareholder equity. That debt is best read against the cash flow the business throws off each year.